Attached files
file | filename |
---|---|
S-1 - FORM S-1 - REGENERX BIOPHARMACEUTICALS INC | w78085sv1.htm |
EX-4.2 - EX-4.2 - REGENERX BIOPHARMACEUTICALS INC | w78085exv4w2.htm |
EX-3.2 - EX-3.2 - REGENERX BIOPHARMACEUTICALS INC | w78085exv3w2.htm |
EX-3.4 - EX-3.4 - REGENERX BIOPHARMACEUTICALS INC | w78085exv3w4.htm |
EX-4.4 - EX-4.4 - REGENERX BIOPHARMACEUTICALS INC | w78085exv4w4.htm |
EX-3.3 - EX-3.3 - REGENERX BIOPHARMACEUTICALS INC | w78085exv3w3.htm |
EX-4.3 - EX-4.3 - REGENERX BIOPHARMACEUTICALS INC | w78085exv4w3.htm |
EX-4.1 - EX-4.1 - REGENERX BIOPHARMACEUTICALS INC | w78085exv4w1.htm |
EX-23.1 - EX-23.1 - REGENERX BIOPHARMACEUTICALS INC | w78085exv23w1.htm |
Exhibit 3.1
RESTATED
CERTIFICATE OF INCORPORATION
OF
OF
ALPHA 1 BIOMEDICALS, INC.
We, J.J. Finkelstein and M. Kathryn Miller, President and Assistant Secretary, respectively,
of Alpha 1 Biomedicals, Inc., a corporation organized and existing under the General Corporation
Law of the State of Delaware, do hereby certify as follows:
FIRST: That the name of the corporation is Alpha 1
Biomedicals, Inc.
SECOND: That the Certificate of Incorporation of the corporation was filed with the Secretary
of State, Dover, Delaware, on May 13, 1982, and amended September 29, 1983.
THIRD: That the text of the Certificate of Incorporation of the corporation, as amended, is
hereby further amended and restated by this Certificate to be and read in its entirety as follows:
1. Name. The name of the corporation is
ALPHA 1 BIOMEDICALS, INC.
(hereinafter called the Corporation)
2. Registered Agent. The address of the Corporations registered office is 229 South State Street, City of
Dover, County of Kent, State of Delaware; and its registered
agent at such address is United States Corporation Company.
- 2 -
3. Purposes. The nature of the business and purposes to be conducted or promoted by
the Corporation are to engage in, carry on and conduct any lawful act or activity for which
corporations may be organized under the General Corporation Law of the State of Delaware.
4. Authorized Capital Stock. The total number of shares of stock which the
Corporation shall have authority to issue is: 10 million (10,000,000), all of which shall be shares
of Common Stock with a par value of one mill ($.001) per share.
5. Adoption, Amendment and Repeal of Bylaws. The Board of Directors shall have the
power to adopt, amend or repeal the Bylaws of the Corporation (except insofar as any Bylaw adopted
by the stockholders otherwise provides).
6. Limitation on Liability of Directors. To the fullest extent permitted by the
General Corporation Law of the State of Delaware, as amended from time to time, no director of the
Corporation shall be liable to the Corporation or its stockholders for breach of his fiduciary duty
as a director.
7. Compromises or Arrangements with Creditors or Stockholders. Whenever a compromise or arrangement is proposed
between this Corporation and its creditors or any class of them
and/or between this Corporation and its stockholders or any class
of them, any court of equitable jurisdiction within the State of
Delaware may, on the application in a summary way of this
Corporation or of any creditor or stockholder thereof or on the
- 3 -
application of any receiver or receivers appointed for this Corporation under the provisions of
Section 291 of Title 8 of the Delaware Code or on the application of trustees in dissolution or of
any receiver or receivers appointed for this Corporation under the provisions of Section 279 of
Title 8 of the Delaware Code, order a meeting of the creditors or class of creditors, and/or of the
stockholders or class of stockholders of this Corporation, as the case may be, to be summoned in
such manner as the said court directs. If a majority in number representing three-fourths in value
of the creditors or class of creditors, and/or of the stockholders or class of stockholders, as the
case may be, agree to any compromise or arrangement and to any reorganization of this Corporation
as a consequence of such compromise or arrangement, said compromise or arrangement and said
reorganization shall, if sanctioned by the court to which the said application has been made, be
binding on all the creditors or class of creditors, and/or on all the stockholders or class of
stockholders, as the case may be, and also on this Corporation.
FOURTH: That the amendments to and
restatement of the Certificate of Incorporation have been duly adopted and approved in accordance
with the provisions of Sections 245 and 242 of the General Corporation Law of the State of Delaware
by the written consent of the holders of not less than a majority of the outstanding stock entitled
to vote thereon and that written notice of such corporate action has been given to those
stockholders who
- 4 -
have not consented in writing, all in accordance with the provisions of Section 228 of the General
Corporation Law.
IN WITNESS WHEREOF, we have signed this Certificate
this 7 day of November, 1986.
ALPHA 1 BIOMEDICALS, INC. |
||||
By: | /s/ J. J. Finkelstein | |||
President | ||||
ATTEST: | ||||
By: |
/s/ M. Kathryn Miller | |||
Assistant Secretary |